NASDAQ
Helix BioPharma Corp. (HBPCF) has a fcf yield of -8.64% as of Friday, May 29, 2026. This represents a 165.97% decrease compared to its 12-month average of -3.25%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.